Education|
December 1988
Plasma Levels of Dantrolene following Oral Administration in Malignant Hyperthermia-susceptible Patients
Gregory C. Allen, M.D., F.R.C.P.C.;
Gregory C. Allen, M.D., F.R.C.P.C.
*Resident in Anesthesia.
Search for other works by this author on:
Charles B. Cattran, M.D., F.R.C.P.C;
Charles B. Cattran, M.D., F.R.C.P.C
†Clinical Lecturer in Anesthesia.
Search for other works by this author on:
Robert G. Peterson, M.D., Ph.D.;
Robert G. Peterson, M.D., Ph.D.
‡Associate Professor of Pediatrics and Pharmacology.
Search for other works by this author on:
Marcel Lalande, Ph.D.
Marcel Lalande, Ph.D.
§Post-doctoral Pharmacology Fellow, Department of Pediatrics.
Search for other works by this author on:
Anesthesiology December 1988, Vol. 69, 900–904.
Citation
Gregory C. Allen, Charles B. Cattran, Robert G. Peterson, Marcel Lalande; Plasma Levels of Dantrolene following Oral Administration in Malignant Hyperthermia-susceptible Patients. Anesthesiology 1988; 69:900–904 doi: https://doi.org/10.1097/00000542-198812000-00016
Download citation file:
